Sandrine Braud

Title: Sandrine Braud: Innovator in Obesity Treatment

Introduction

Sandrine Braud is a prominent inventor based in Ieuville-sur-Orge, France. She has made significant contributions to the field of biotechnology, particularly in the treatment of obesity and related metabolic disorders. Her innovative work has led to the development of novel compounds that have the potential to transform therapeutic approaches in this area.

Latest Patents

Sandrine Braud holds a patent for "Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism." This patent includes novel compounds, particularly derivatives of boroarginine, boroornithine, and borolysine, which selectively modulate, regulate, and inhibit enteropeptidase. The patent also covers pharmaceutical compositions and methods to treat excess weight, obesity, and diseases associated with abnormal fat metabolism. She has 1 patent to her name.

Career Highlights

Sandrine Braud is associated with Obe Therapy Biotechnology, where she applies her expertise in biotechnology to develop innovative solutions for obesity treatment. Her work is characterized by a commitment to advancing scientific knowledge and improving patient outcomes.

Collaborations

Sandrine collaborates with notable professionals in her field, including Itzik Harosh and Marco A Ciufolini. These collaborations enhance her research and contribute to the development of effective therapeutic strategies.

Conclusion

Sandrine Braud is a trailblazer in the field of biotechnology, focusing on innovative treatments for obesity and metabolic disorders. Her contributions through her patent and collaborations highlight her dedication to improving health outcomes.